Premature aging is a feature of the genetic disorder dyskeratosis congenita (DC). DC is caused by progressive shortening of telomeres, sequences that protect chromosome ends. Telomere shortening occurs in the normal process of aging, and mutations in telomerase, the enzyme that maintains telomere length, can accelerate this process. Although mouse models have provided insight into the role of telomeres in premature aging, they do not recapitulate all human symptoms. Here, María Cayuela’s group show that telomerase-deficient zebrafish demonstrate the hallmark features of premature aging in the first generation, in contrast with mice, which have to be bred for several generations. Intriguingly, the zebrafish mutants show ‘anticipation’ (onset of disease at a younger age in the next generation), which is also apparent in individuals with DC. Reintroduction of telomerase is able to rescue telomere length, confirming the importance of telomerase dosage and paving the way for studies of new therapeutics based on telomerase reactivation. Page 1101
- Written by editorial staff. © 2013. Published by The Company of Biologists Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly cited.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Editor’s Choice – Altered expression of the Cdk5 activator-like protein, Cdk5α, causes neurodegeneration, in part by accelerating the rate of aging
By developing a comprehensive and quantitative metric for physiological age of Drosophila, Edward Giniger and colleagues show that a neurodegeneration mutant produces its effects in part by accelerating the absolute rate of aging.
First Person interviews
Have you seen our interviews with the early-career first authors of our papers? Recently, we caught up with first authors Sarah Foriel, Henna Myllymäki and Mirja Niskanen, Wenqing Zhou, Rifdat Aoidi and Amy Irving.
Review – Metastasis in context: modeling the tumor microenvironment with cancer-on-a-chip approaches
In a new Review article, Jaap M. J. den Toonder and colleagues evaluate the recent contributions of cancer-on-a-chip models to our understanding of the tumor microenvironment and its role in the onset of metastasis. The authors also provide an outlook for future applications of this emerging technology.
DMM Conference Travel Grants
Are you an early career scientist with plans to attend a scientific meeting, conference, workshop or course relating to the areas of research covered by DMM? The next round of applications for DMM Conference Travel Grants closes on 4 May 2018. Find out more here and get your application in soon.
Why should you publish your next paper in DMM?
DMM aims to promote human health by encouraging collaboration between basic and clinical researchers, covering a diverse range of diseases, approaches and models. Our Editors are all active researchers in the field – your peers, colleagues and mentors, who know how much work has gone into every paper. Recently, we have introduced format-free submission, and we accept peer review reports from other journals, making submission as easy as possible for our authors. Send us your next great paper – publish with us and you'll be in good company.